183 related articles for article (PubMed ID: 38078714)
1. Role of transcriptomic and genomic analyses in improving the comprehension of cefiderocol activity in
Stracquadanio S; Nicolosi A; Privitera GF; Massimino M; Marino A; Bongiorno D; Stefani S
mSphere; 2024 Jan; 9(1):e0061723. PubMed ID: 38078714
[TBL] [Abstract][Full Text] [Related]
2. Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability.
Stracquadanio S; Bonomo C; Marino A; Bongiorno D; Privitera GF; Bivona DA; Mirabile A; Bonacci PG; Stefani S
Microbiol Spectr; 2022 Oct; 10(5):e0234722. PubMed ID: 36173300
[TBL] [Abstract][Full Text] [Related]
3. First detection of a cefiderocol-resistant and extensively drug-resistant Acinetobacter baumannii clinical isolate in Bulgaria.
Strateva T; Peykov S
Acta Microbiol Immunol Hung; 2024 Mar; 71(1):25-36. PubMed ID: 38261035
[TBL] [Abstract][Full Text] [Related]
4. Induced Heteroresistance in Carbapenem-Resistant
Mezcord V; Escalante J; Nishimura B; Traglia GM; Sharma R; Vallé Q; Tuttobene MR; Subils T; Marin I; Pasteran F; Actis LA; Tolmasky ME; Bonomo RA; Rao G; Ramirez MS
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511511
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Iron-Transport Systems and β-Lactamases to Cefiderocol Resistance in Clinical Isolates of Acinetobacter baumannii Endemic to New York City.
Asrat H; Samaroo-Campbell J; Ata S; Quale J
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0023423. PubMed ID: 37212653
[TBL] [Abstract][Full Text] [Related]
6. Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3.
Malik S; Kaminski M; Landman D; Quale J
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868330
[TBL] [Abstract][Full Text] [Related]
7. Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence.
Sheldon JR; Skaar EP
PLoS Pathog; 2020 Oct; 16(10):e1008995. PubMed ID: 33075115
[TBL] [Abstract][Full Text] [Related]
8. Fimsbactin and Acinetobactin Compete for the Periplasmic Siderophore Binding Protein BauB in Pathogenic Acinetobacter baumannii.
Bohac TJ; Fang L; Giblin DE; Wencewicz TA
ACS Chem Biol; 2019 Apr; 14(4):674-687. PubMed ID: 30785725
[TBL] [Abstract][Full Text] [Related]
9. A Selective Culture Medium for Screening Cefiderocol Resistance in
Ibrahim A; Bouvier M; Sadek M; Decousser JW; Poirel L; Nordmann P
J Clin Microbiol; 2023 Jul; 61(7):e0188322. PubMed ID: 37338403
[TBL] [Abstract][Full Text] [Related]
10. Iron Acquisition Mechanisms and Their Role in the Virulence of Acinetobacter baumannii.
Cook-Libin S; Sykes EME; Kornelsen V; Kumar A
Infect Immun; 2022 Oct; 90(10):e0022322. PubMed ID: 36066263
[TBL] [Abstract][Full Text] [Related]
11. Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in
Liu X; Chang Y; Xu Q; Zhang W; Huang Z; Zhang L; Weng S; Leptihn S; Jiang Y; Yu Y; Hua X
mSystems; 2023 Aug; 8(4):e0129122. PubMed ID: 37345941
[No Abstract] [Full Text] [Related]
12. Acinetobacter baumannii response to cefiderocol challenge in human urine.
Nishimura B; Escalante J; Tuttobene MR; Subils T; Mezcord V; Pimentel C; Georgeos N; Pasteran F; Rodriguez C; Sieira R; Actis LA; Tolmasky ME; Bonomo RA; Ramirez MS
Sci Rep; 2022 May; 12(1):8763. PubMed ID: 35610334
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii.
Raro OHF; Bouvier M; Kerbol A; Decousser JW; Poirel L; Nordmann P
Eur J Clin Microbiol Infect Dis; 2023 Dec; 42(12):1511-1518. PubMed ID: 37910268
[TBL] [Abstract][Full Text] [Related]
14. Activity of Cefiderocol Against
Iregui A; Khan Z; Landman D; Quale J
Microb Drug Resist; 2020 Jul; 26(7):722-726. PubMed ID: 32031915
[TBL] [Abstract][Full Text] [Related]
15. Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii.
Poirel L; Sadek M; Nordmann P
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0087721. PubMed ID: 34252309
[TBL] [Abstract][Full Text] [Related]
16. Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii.
Zimbler DL; Penwell WF; Gaddy JA; Menke SM; Tomaras AP; Connerly PL; Actis LA
Biometals; 2009 Feb; 22(1):23-32. PubMed ID: 19130255
[TBL] [Abstract][Full Text] [Related]
17. Distinctive Roles of Two Acinetobactin Isomers in Challenging Host Nutritional Immunity.
Kim M; Kim DY; Song WY; Park SE; Harrison SA; Chazin WJ; Oh MH; Kim HJ
mBio; 2021 Oct; 12(5):e0224821. PubMed ID: 34517755
[TBL] [Abstract][Full Text] [Related]
18. Acinetobactin Isomerization Enables Adaptive Iron Acquisition in Acinetobacter baumannii through pH-Triggered Siderophore Swapping.
Shapiro JA; Wencewicz TA
ACS Infect Dis; 2016 Feb; 2(2):157-68. PubMed ID: 27624967
[TBL] [Abstract][Full Text] [Related]
19. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan.
Yamano Y; Ishibashi N; Kuroiwa M; Takemura M; Sheng WH; Hsueh PR
J Glob Antimicrob Resist; 2022 Mar; 28():120-124. PubMed ID: 34958997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
